A new report shows lawyers are already managing the risks of unknowingly facilitating money laundering and don’t need to be subjected to “an extreme, disproportional and potentially damaging AML/CTF regime”, according to the Law Council of Australia.
Twenty-five barristers have joined the rank of silk in NSW, including one who represented AMP in a class action that settled for $100 million and another who is assisting the Commonwealth in its fight to recoup $325 million in excess subsidies in a dispute over generic Plavix.
Treasurer Jim Chalmers has announced an overhaul of the Productivity Commission following a review which found a “culture of sexism, sexual harassment, bullying and discrimination”.
The judge overseeing a slow moving class action against four AMP subsidiaries and two trustees over alleged excessive superannuation fees has expressed his frustration with delays in the case, fixing the case for trial over the wealth manager’s protest.
The ASX-listed Shine Lawyers has earned marks for improvement in a review by ASIC of its disclosures relating to interest on litigation funding loans, the corporate regulator said Thursday.
Agricultural giant Graincorp has hit back at a class action filed by rural Victorians who allege that a loud and foul-smelling oilseed factory run by the “high-handed” company has reduced the value of their homes and affected their health.
A failed class action against Volkswagen over Takata airbags is seeking special leave from the High Court, arguing an appeals court was wrong to find a reasonable consumer would be comfortable with an airbag that posed a potential risk of rupture.
United Petroleum, which is facing a franchisee class action over allegedly loss-making Pie Face stores, is resisting a plaintiff law firm’s bid for “a right of veto” over the petrol giant’s communications with group members, even those not represented by the firm.
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.